ClearOne, Inc. entered into a Merger Agreement with Cortigent, Inc. and Vivani Medical, Inc. to acquire Cortigent via a merger-sub subsidiary. As consideration for Cortigent common stock, Vivani will receive 12,500,000 shares of ClearOne common stock. ClearOne plans to file a Form S-1 to raise between $10,000,000 and $15,000,000 through a unit-based financing-round. The post-closing board of directors will consist of five members, including Adam Mendelsohn (Chairman) and Jonathan Adams (President & CEO). ClearOne operates in the technology and audio-visual solutions industry.

On June 30, 2026, ClearOne, Inc. entered into a Loan Agreement with First Finance Ltd. to secure a loan of up to $1,000,000 in aggregate, advanced in tranches of $500,000 initially and $250,000 for subsequent tranches. The loan carries an 11% annual interest rate and matures on December 30, 2026. ClearOne, Inc. intends to use the proceeds for general working capital purposes. ClearOne, Inc. provides audio and visual technology solutions for various industries.